Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Pyxis Oncology, Inc. | Director | Common Stock | 96.8K | $136K | $1.40 | Mar 26, 2024 | Direct |
Xilio Therapeutics, Inc. | Director | Common Stock | 9.44K | $7.84K | $0.83 | Oct 21, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PYXS | Pyxis Oncology, Inc. | Mar 26, 2024 | 1 | $0 | 4 | Mar 28, 2024 | Director |
PYXS | Pyxis Oncology, Inc. | Mar 24, 2023 | 1 | $0 | 4 | Mar 28, 2023 | Director |
PYXS | Pyxis Oncology, Inc. | Aug 11, 2022 | 1 | $0 | 4 | Aug 15, 2022 | Director |
PYXS | Pyxis Oncology, Inc. | Aug 11, 2022 | 0 | $0 | 3 | Aug 15, 2022 | Director |
XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 0 | $0 | 3 | Oct 21, 2021 | Director |